An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Bausch + Lomb Publishes Update Presentation for the 41st Annual J.P. Morgan Healthcare Conference
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a global eye health leader, will present a company update at the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023, at 3:00 p.m. PT. This presentation will highlight recent performance, achievements, and future goals for the company. The presentation can be accessed on their Investor Relations page. With over 400 products, Bausch + Lomb is committed to enhancing vision for individuals worldwide, supported by a robust global presence.
Positive
Participation in the prestigious J.P. Morgan Healthcare Conference showcases company transparency and strategic engagement with investors.
The update presentation is likely to highlight growth prospects and recent achievements, potentially boosting investor confidence.
Negative
None.
VAUGHAN, Ontario--(BUSINESS WIRE)--
Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live better, has published a company update presentation designed to complement remarks that will be provided by management at 3:00 p.m. PT (6:00 p.m. ET) today, Jan. 9, 2023, during the 41st Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation provides an overview of the Company’s recent performance and achievements, and offers insight into future goals and catalysts for 2023 and beyond.
The presentation is available on the Investor Relations page of the Bausch + Lomb website at: https://ir.bausch.com/investors/events-presentations. A live webcast and audio archive of the event will also be available on the Investor Relations page of the Company’s web site.
About Bausch + Lomb
Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on Twitter, LinkedIn, Facebook and Instagram.
